Rock Springs Capital Management’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-1,734,037
Closed -$3.83M 128
2023
Q2
$3.83M Hold
1,734,037
0.09% 93
2023
Q1
$4.4M Hold
1,734,037
0.11% 93
2022
Q4
$3.24M Hold
1,734,037
0.08% 96
2022
Q3
$4.46M Hold
1,734,037
0.12% 96
2022
Q2
$3.35M Buy
1,734,037
+7,400
+0.4% +$14.3K 0.1% 103
2022
Q1
$5.13M Buy
1,726,637
+29,532
+2% +$87.7K 0.13% 103
2021
Q4
$7.62M Buy
1,697,105
+32,091
+2% +$144K 0.18% 102
2021
Q3
$8.09M Buy
1,665,014
+10,300
+0.6% +$50.1K 0.17% 115
2021
Q2
$11.3M Sell
1,654,714
-30,000
-2% -$205K 0.22% 106
2021
Q1
$11.9M Buy
1,684,714
+4,100
+0.2% +$28.9K 0.26% 100
2020
Q4
$10.5M Buy
1,680,614
+7,200
+0.4% +$45.1K 0.22% 112
2020
Q3
$9.05M Buy
1,673,414
+18,250
+1% +$98.7K 0.23% 106
2020
Q2
$8.64M Buy
1,655,164
+128,854
+8% +$673K 0.24% 108
2020
Q1
$4.81M Buy
1,526,310
+1,151,310
+307% +$3.63M 0.2% 101
2019
Q4
$1.51M Sell
375,000
-75,000
-17% -$302K 0.05% 121
2019
Q3
$1.94M Hold
450,000
0.08% 126
2019
Q2
$1.8M Hold
450,000
0.07% 123
2019
Q1
$2.41M Hold
450,000
0.09% 117
2018
Q4
$2.31M Hold
450,000
0.11% 121
2018
Q3
$4.37M Hold
450,000
0.16% 123
2018
Q2
$4.59M Hold
450,000
0.18% 120
2018
Q1
$5.85M Hold
450,000
0.25% 109
2017
Q4
$8.06M Hold
450,000
0.37% 84
2017
Q3
$11.3M Sell
450,000
-150,000
-25% -$3.77M 0.52% 65
2017
Q2
$14.5M Buy
600,000
+74,500
+14% +$1.8M 0.73% 48
2017
Q1
$10.1M Hold
525,500
0.58% 56
2016
Q4
$8.09M Buy
525,500
+23,000
+5% +$354K 0.54% 57
2016
Q3
$6.54M Buy
502,500
+84,000
+20% +$1.09M 0.41% 72
2016
Q2
$5.82M Buy
418,500
+195,500
+88% +$2.72M 0.43% 77
2016
Q1
$3.38M Buy
223,000
+192,173
+623% +$2.92M 0.28% 97
2015
Q4
$585K Buy
+30,827
New +$585K 0.04% 118